NM_005732.4(RAD50):c.1817A>G (p.Gln606Arg) AND Hereditary cancer-predisposing syndrome
- Germline classification:
- Uncertain significance (2 submissions)
- Last evaluated:
- Jun 5, 2024
- Review status:
- Somatic classification
of clinical impact: - None
- Review status:
- Somatic classification
of oncogenicity: - None
- Review status:
- Record status:
- current
- Accession:
- RCV000558289.13
Allele description [Variation Report for NM_005732.4(RAD50):c.1817A>G (p.Gln606Arg)]
NM_005732.4(RAD50):c.1817A>G (p.Gln606Arg)
Condition(s)
- Name:
- Hereditary cancer-predisposing syndrome
- Synonyms:
- Neoplastic Syndromes, Hereditary; Tumor predisposition; Cancer predisposition; See all synonyms [MedGen]
- Identifiers:
- MONDO: MONDO:0015356; MeSH: D009386; MedGen: C0027672
-
Mus musculus indoleamine 2,3-dioxygenase 1 (Ido1), transcript variant 1, mRNA
Mus musculus indoleamine 2,3-dioxygenase 1 (Ido1), transcript variant 1, mRNAgi|2292593734|ref|NM_008324.3|Nucleotide
-
maturase K, partial (chloroplast) [Rhexia nashii]
maturase K, partial (chloroplast) [Rhexia nashii]gi|2496527795|gb|WGL40517.1|Protein
-
Mus musculus serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiprot...
Mus musculus serine (or cysteine) peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9, mRNA (cDNA clone MGC:163918 IMAGE:40130564), complete cdsgi|124376685|gb|BC132287.1|Nucleotide
Your browsing activity is empty.
Activity recording is turned off.
See more...Assertion and evidence details
Last Updated: Sep 29, 2024